| Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors S Sofi, U Mehraj, H Qayoom, S Aisha, A Almilaibary, M Alkhanani, MA Mir Medical Oncology 39 (9), 133, 2022 | 88 | 2022 |
| Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications S Sofi, U Mehraj, H Qayoom, S Aisha, SMB Asdaq, A Almilaibary, MA Mir Medical oncology 39 (6), 106, 2022 | 76 | 2022 |
| Unveiling the mechanisms and challenges of cancer drug resistance SU Khan, K Fatima, S Aisha, F Malik Cell Communication and Signaling 22 (1), 109, 2024 | 70 | 2024 |
| Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: a comprehensive analysis U Mehraj, S Aisha, S Sofi, MA Mir Advances in Cancer Biology-Metastasis 4, 100037, 2022 | 48 | 2022 |
| Redox balance and autophagy regulation in cancer progression and their therapeutic perspective SU Khan, K Fatima, S Aisha, B Hamza, F Malik Medical Oncology 40 (1), 12, 2022 | 38 | 2022 |
| Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study H Qayoom, U Mehraj, S Sofi, S Aisha, A Almilaibary, M Alkhanani, MA Mir Medical oncology 39 (10), 158, 2022 | 33 | 2022 |
| Cell cycle dysregulation in breast cancer MA Mir, SU Khan, S Aisha Therapeutic potential of cell cycle kinases in breast cancer, 103-131, 2023 | 14 | 2023 |
| Role of tumor microenvironment in breast cancer and targeted therapies MA Mir Elsevier, 2022 | 14 | 2022 |
| Integrating immunotherapy with chemotherapy: a new approach to drug repurposing H Qayoom, U Mehraj, S Aisha, S Sofi, MA Mir Drug repurposing molecular aspects and therapeutic applications, 2021 | 12 | 2021 |
| Immuno-onco-metabolism and Therapeutic Resistance MA Mir, S Aisha, S Nisar, H Qayoom, U Mehraj Immuno-oncology crosstalk and metabolism, 45-89, 2022 | 10 | 2022 |
| Chapter 1 - Human pathogenic microbes (bacterial and fungal) and associated diseases SSH Manzoor Ahmad Mir, Ubaid Rasool, Shariqa Aisha, Bader Alshehri Human Pathogenic Microbes 1, Pages 1-30, 2022 | 9 | 2022 |
| Human pathogenic microbes: Diseases and concerns MA Mir Academic Press, 2022 | 9 | 2022 |
| Chapter 1 - Introduction to various types of cancers SS Manzoor Ahmad Mir, Shariqa Aisha Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies 1 …, 2022 | 8* | 2022 |
| Chapter1 - Triple-negative breast cancer - an aggressive subtype of breast cancer S Aisha Combinational Therapy in Triple Negative Breast Cancer 1, Pages 1-28, 2022 | 7* | 2022 |
| Combinational therapy in triple negative breast cancer MA Mir Academic Press, 2022 | 7 | 2022 |
| Chapter 3 - Role of cancer-associated fibroblasts in tumor microenvironment SA Manzoor Ahmad Mir, Shazia Sofi Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies 1 …, 2022 | 6* | 2022 |
| Response of therapy in cell-cycle regulatory genes in breast cancer MA Mir, S Aisha, K Fatima, FA Malik Therapeutic potential of cell cycle kinases in breast cancer, 335-353, 2023 | 4 | 2023 |
| Chapter 3 - Current therapeutics and treatment options in TNBC UM Manzoor A. Mir *, Shariqa Aisha * Combinational Therapy in Triple Negative Breast Cancer 1, Pages 61-94, 2022 | 4* | 2022 |
| Chapter 10 - Recent trends in the development of bacterial and fungal vaccines SA Manzoor Ahmad Mir, Muhammad Usman, Hafsa Qadri Human Pathogenic Microbes 1, Pages 233-259, 2022 | 4* | 2022 |
| Chapter 8 - Different drug delivery approaches in combinational therapy in TNBC UM Manzoor A. Mir *, Shariqa Aisha * Combinational Therapy in Triple Negative Breast Cancer 1, Pages 201-230, 2022 | 3 | 2022 |
Dr Manzoor Ahmad MirUniversity of KashmirVerified email at kashmiruniversity.ac.in